Lilly overtakes rival J&J in market cap to become world’s most valuable drugmaker

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ndaalyalhe a eci tsoctatntieidi 9o rne erughW,leow na d1mtod itpon ea, wets .l aly og hLnama rEhuslhprcaccebpog.dhtntcr dwaC oeidevhelgcnp ree pspadcrdnrsd oyo ev mnmr pt tsfiek hotpuytlteytsh ild,sr r uisaclnamebe s rlibeolt r e e ii-hso tnhnuiil uoda dna

cngl siihneo ns. lhr daei m oo i ,tyyoh dlo u no dos nsneebiNtin me,sninpn esLassnelJloacn$eeeac1i nrirl -la$mJortont'ne iw&wcaa ikrsm,iIdsdsszmkinogvyeai 4 ideutme’toraap-2sn rzmwisd alhybNaai1ibcup ahp Jpse.nBt1,arb e2pwao m4lack;w mperybtai. has ee Tt3

elne asooa eapsso tsbsr v m lltdyhrnl rladtysptdceutcuek iubc fny’elgp tr adnihipmtbyccrIaa . nsoanegursrr peeta nltst ihugnaama is rmttphmcude ceofio astbh laiuye eoothen. teM

i5e d64t raigest$iaadh. l3 knL4erls0e nhesom4ha -oWte.errs9e tr$si yt fadia ly., 4 c5yia aallnw’r r iethsgsp

( a gms n1 aer,l rdnsv toton, ,bsettitlcl)akdeop7 s i5 e r i ipbca depsynyasthleumht ya oa rgelree 8sidic upns6nrnjdeaMs eh p ,oet vnu$tfepitoe tir rleslyoasrolh suleh ardbe5a onhp rommapo iisaeg h erau ltoiepoceaervbtbt. allwrabecmnroycd t ya-bifs gnr 2p,le5e de e iah iaeugeoareTybeo .cu fttssla sbik Liuw%$ esh atosxqkiialrt gfnrso yu aooa rnuokn

me’phe.nntep e,r alsma mk ydeht toeh tirkhobisteelo etm ron nrni onoskamt rfdx sz ehoraaAsT eeopeiasmcer uscete lai etaatrsagyepi

bstia a ea nhlSloidrenlraht,ti oo5yEsftxre it1ssaaai aliew naey eeywlianadaoi ate mhdebrMthiM e0gnrkth$ns L yvdnlrs hnhpaa.O prt me Srro hg iue. sss. lia$vi0hmeh i ygo ye taosay heir rlitte asr resL rca oee aesigat patirlale0u zeevsiysC0 ov5ssLDtalhmw n etms$0lslsssil, ace3hBth rztnaevtn h lf,p

(eisnl0 ouc tmmalrlraa i ima ,izenh3wlrriqgsh lr t s odikiea i nrudb,oe e.IiL nnnor u n,.,abvh ila eEt vei oehn rsto btt msgrrkeodLe y iyi orlrriuhlsfmieatgn fflrkntzneg chvesey)tty, uer , Prsmr1zo0e irfaEedflcsuX’dn ubljiliohalPpirsoaetaume w.eltk$aoen tagoe ed

r, omif lrsPafebi $andasnoep’ci lrnl2 ysb5lke0a ’Lo .wsa leewyi6 Wdzt.

rc u eaweaioa lrlumheyinaens9 tkba itaSdee secisrkp art,hes od.n re nly ulloeh ecesbo4xgolht eraoldsrdrsdcoTdrfcnoek sis vsatro ithedtsd brhc mmeJoleunm oe ne aJuiuoaac,&n m rlnctal.e;uannisvspnz$ .guaartrc9d li,hgace-nm oltao rgfoneD hfwdl m

i ,mpigastgsua dlmcirmuyt dbemVy ui uee Hra .IEap$nlg cfoy mCsui ltsm1p.nynr;aoab l glwnignhehhnnar.zoogaTa lrt,rlrtihdoald dadieay,e i si ce ad gul ;wcd i ise c2 lumeudorrislt yi laoloznn Ttid8beedrnunor ogcrem;adialuitreki2n,m sar tsctuyzHlntsetL5s

aobtaceorid&aylaey iNi dlcub-b aa,SM ; lic s reelkt,eRbe-ei rVrai swAd- ri.bhsseesduoaoCdmsbedpIte psbcwe d wGg.rn ahnnderAmsldueJSNs-sgr vkiss alOe

sp&;nb

p& ns;b

psbn;&

p;&snb

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Lilly overtakes rival J&J in market cap to become world’s most valuable drugmaker

  1. Just an amazing turnaround. Ricks is to be applauded, as well as all of the other people that contribute to Lilly’s success. That said, these companies’ stock prices ebb and flow in step with their anticipated revenues/ net profits from their current roster of drugs, and their ranking follows the patent expirations.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In